Spots Global Cancer Trial Database for Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions
Official Title: A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fed Conditions
Study ID: NCT01367626
Conditions
Study Description
Brief Summary: The objective of this study was to prove the bioequivalence of Letrozole Tablet under fed conditions.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: MALE
Healthy Volunteers: Yes
Locations
PRACS Institute, Ltd., Fargo, North Dakota, United States
Contact Details
Name: Alan K Copa, PharmD
Affiliation: PRAC Institute, Ltd.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
